FindTrial
Sign In

Influenza vaccination.

3 trials

Sponsors

St. Antonius Ziekenhuis Nieuwegein, UMCG, University Medical Center Groningen, the Netherlands

Conditions

1. Rheumatoid Arthritis (NLD: reumatoide artritis)1. Systemic lupus erythematosuslymphoma, non-hodgkins lymphoma, NHL, vaccination, influenza, humoral response, rituximab. lymfoom, non-hodgekin's lymfoma, NHL, vaccinatie, influenza, humorale respons, rituximab.

Unknown Phase

An open-label pilot study on the effects of trivalent inactivated influenza vaccination (Influvac®) in rheumatoid arthritis patients treated with rituximab.
RecruitingNL-OMON25369
UMCG1. Rheumatoid Arthritis (NLD: reumatoide artritis)
Start: 2007-10-01Target: 70Updated: 2024-02-28
Influenza vaccination in patients with systemic lupus erythematosus and Wegener's granulomatosis.
Active, not recruitingNL-OMON25590
University Medical Center Groningen, the Netherlands1. Systemic lupus erythematosus
Start: 2005-10-01Target: 240Updated: 2024-02-28
Efficienty of vaccination in patients with cancer who are treated with chemotherapy.
Active, not recruitingNL-OMON23415
St. Antonius Ziekenhuis Nieuwegeinlymphoma, non-hodgkins lymphoma, NHL, vaccination, influenza, humoral response, rituximab. lymfoom, non-hodgekin's lymfoma, NHL, vaccinatie, influenza, humorale respons, rituximab.
Start: 2012-09-01Target: 160Updated: 2024-06-11